BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 35691028)

  • 1. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
    Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J
    Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
    Pierrotti LC; Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Tan BH; Carratalà J; Oriol I; Paul M; Cohen-Sinai N; López-Medrano F; San-Juan R; Montejo M; Freire MP; Cordero E; David MD; Merino E; Mehta Steinke S; Grossi PA; Cano Á; Seminari EM; Valerio M; Gunseren F; Rana M; Mularoni A; Martín-Dávila P; van Delden C; Hamiyet Demirkaya M; Koçak Tufan Z; Loeches B; Iyer RN; Soldani F; Eriksson BM; Pilmis B; Rizzi M; Coussement J; Clemente WT; Roilides E; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J; Aguado JM;
    Transpl Infect Dis; 2021 Jun; 23(3):e13520. PubMed ID: 33222379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients.
    Wang R; Han JH; Lautenbach E; Tamma PD; Thom KA; Alby K; Blumberg EA; Bilker WB; Werzen A; Omorogbe J; Tolomeo P; Anesi JA
    Transpl Infect Dis; 2021 Aug; 23(4):e13599. PubMed ID: 33724633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant Gram-negative infection in solid organ transplant recipients: implications for outcome and treatment.
    Silva JT; Fernández-Ruiz M; Aguado JM
    Curr Opin Infect Dis; 2018 Dec; 31(6):499-505. PubMed ID: 30299353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
    Kohler P; Wolfensberger A; Stampf S; Brönnimann A; Boggian K; van Delden C; Favre M; Hirzel C; Khanna N; Kuster SP; Manuel O; Neofytos D; Ragozzino S; Schreiber PW; Walti L; Mueller NJ;
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):50. PubMed ID: 33678189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pre-transplant carbapenem-resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes.
    Taimur S; Pouch SM; Zubizarreta N; Mazumdar M; Rana M; Patel G; Freire MP; Pellett Madan R; Kwak EJ; Blumberg E; Satlin MJ; Pisney L; Clemente WT; Zervos MJ; La Hoz RM; Huprikar S
    Clin Transplant; 2021 Apr; 35(4):e14239. PubMed ID: 33527453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.
    Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L
    Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.
    Luo H; Chen X; Jiang Z; Yan Q
    Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients.
    Pouch SM
    Curr Opin Organ Transplant; 2021 Aug; 26(4):424-431. PubMed ID: 34148979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial.
    Stewart AG; Harris PNA; Chatfield MD; Littleford R; Paterson DL
    Trials; 2021 Apr; 22(1):301. PubMed ID: 33888139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2021 Apr; 72(7):e169-e183. PubMed ID: 33106864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
    Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J
    Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
    Winters HA; Parbhoo RK; Schafer JJ; Goff DA
    Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2022 Aug; 75(2):187-212. PubMed ID: 35439291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation.
    Pilmis B; Weiss E; Scemla A; Le Monnier A; Grossi PA; Slavin MA; Van Delden C; Lortholary O; Paugam-Burtz C; Zahar JR
    Clin Microbiol Infect; 2023 Jan; 29(1):38-43. PubMed ID: 35716912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients.
    Anesi JA; Lautenbach E; Thom KA; Tamma PD; Blumberg EA; Alby K; Bilker WB; Werzen A; Ammazzalorso A; Tolomeo P; Omorogbe J; Pineles L; Han JH
    Transplantation; 2023 Jan; 107(1):254-263. PubMed ID: 35856636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
    Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
    Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.
    Pérez-Nadales E; Fernández-Ruiz M; Natera AM; Gutiérrez-Gutiérrez B; Mularoni A; Russelli G; Pierrotti LC; Pinheiro Freire M; Falcone M; Tiseo G; Tumbarello M; Raffaelli F; Abdala E; Bodro M; Gervasi E; Fariñas MC; Seminari EM; Castón JJ; Marín-Sanz JA; Gálvez-Soto V; Rana MM; Loeches B; Martín-Dávila P; Pascual Á; Rodríguez-Baño J; Aguado JM; Martínez-Martínez L; Torre-Cisneros J;
    Am J Transplant; 2023 Jul; 23(7):1022-1034. PubMed ID: 37028515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2021 Apr; 72(7):1109-1116. PubMed ID: 33830222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients.
    Hong Nguyen M; Shields RK; Chen L; William Pasculle A; Hao B; Cheng S; Sun J; Kline EG; Kreiswirth BN; Clancy CJ
    Clin Infect Dis; 2022 Feb; 74(3):395-406. PubMed ID: 33970222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.